China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Short Interest Update

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTCGet Free Report) saw a significant increase in short interest during the month of May. As of May 31st, there was short interest totalling 137,400 shares, an increase of 47.4% from the May 15th total of 93,200 shares. Approximately 3.5% of the shares of the company are sold short. Based on an average trading volume of 4,230,000 shares, the days-to-cover ratio is presently 0.0 days.

China SXT Pharmaceuticals Trading Up 7.5%

NASDAQ:SXTC opened at $1.86 on Wednesday. The stock has a 50-day simple moving average of $1.83 and a two-hundred day simple moving average of $2.80. China SXT Pharmaceuticals has a 52-week low of $0.95 and a 52-week high of $11.92. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.40 and a quick ratio of 1.35.

China SXT Pharmaceuticals Company Profile

(Get Free Report)

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.

See Also

Receive News & Ratings for China SXT Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China SXT Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.